InflaRx (IFRX) Amortization of Deferred Charges (2016 - 2018)
InflaRx's (IFRX) quarterly Amortization of Deferred Charges came in at $515266.2 in Q3 2018, down 48.35% year-over-year from $997628.7 in Q3 2017, and up 631.77% quarter-over-quarter from $70413.2 in Q2 2018.
Analysis
InflaRx (IFRX) Amortization of Deferred Charges (2016 - 2018) Analysis & Trends
InflaRx has disclosed Amortization of Deferred Charges across 3 years of filings, most recently posting $515266.2 for Q3 2018.
- In Q3 2018, Amortization of Deferred Charges fell 48.35% year-over-year to $515266.2; the TTM figure through Sep 2018 stood at $6.1 million (up 64.31% YoY), while the FY2017 annual figure was $5.6 million, up 145.1% from the prior year.
- Amortization of Deferred Charges came in at $515266.2 for Q3 2018 at InflaRx, up from $70413.2 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $2.8 million in Q4 2017 to a low of $70413.2 in Q2 2018.
- Average Amortization of Deferred Charges over 3 years is $1.2 million, with a median of $930970.7 recorded in 2016.
- The largest YoY upside for Amortization of Deferred Charges was 210.33% in 2018 against a maximum downside of 92.39% in 2018.
- Over 3 years, Amortization of Deferred Charges stood at $936120.9 in 2016, then surged by 204.26% to $2.8 million in 2017, then sank by 81.91% to $515266.2 in 2018.
- Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $515266.2 in Q3 2018, $70413.2 in Q2 2018, and $2.7 million in Q1 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | InflaRx | 139.29 Mn | -44.96 Mn | 2.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | 515,266.22 |
| Jun 30, 2018 | 70,413.22 |
| Mar 31, 2018 | 2.69 Mn |
| Dec 31, 2017 | 2.85 Mn |
| Sep 30, 2017 | 997,628.71 |
| Jun 30, 2017 | 925,820.53 |
| Mar 31, 2017 | 866,175.81 |
| Dec 31, 2016 | 936,120.90 |